Last reviewed · How we verify
NCT06670391
A Retrospective Study in Patients With Liver Injury After the Use of Novel Antineoplastic Agents
trial in Liver Injury in 2,000 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2025
Quick facts
| Lead sponsor | Drug Induced Liver Disease Study Group |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 May 2023 |
| Primary completion | 30 April 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Conditions studied
- Liver Injury — all drugs for Liver Injury →
- Liver Injury, Drug-Induced — all drugs for Liver Injury, Drug-Induced →
Sponsor
Drug Induced Liver Disease Study Group — full company profile →
Who can join
18 and older, any sex, with Liver Injury or Liver Injury, Drug-Induced. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an open-enrollment, retrospective, observational study without interventions. Its primary objective is to understand 1) incidence of liver injury among all the hospitalized patient from participating centers after the administration of immune checkpoint inhibitors or molecularly targeted agents; 2) epidemiologic and clinical characteristics of liver injury, including suspected medications, clinical types, histological characteristics, severity, treatment and outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06670391
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Injury
Currently open trials in the same condition.
- NCT06864481 — Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis · recruiting
- NCT07050550 — A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury · recruiting
- NCT06080308 — Liver Ischemia-reperfusion Injury and Clinical Data Analysis · recruiting
- NCT04937868 — Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients · recruiting
Other Drug Induced Liver Disease Study Group trials
Trials by the same sponsor.
- NCT02944552 — The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06670391 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Drug Induced Liver Disease Study Group
- Last refreshed: 4 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670391.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing